Karyopharm Therapeutics Inc.
NASDAQ:KPTI
0.9032 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 52.891 | 135.188 | 190.459 | 85.918 | 128.858 | 118.021 | 68.997 | 49.663 | 58.358 | 150.609 | 155.974 | 0.391 | 6.512 |
| Short Term Investments
| 139.212 | 142.779 | 38.156 | 163.322 | 133.098 | 210.178 | 77.472 | 79.889 | 117.275 | 55.115 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 192.103 | 277.967 | 228.615 | 273.455 | 263.972 | 328.199 | 146.469 | 129.552 | 175.633 | 205.724 | 155.974 | 0.391 | 6.512 |
| Net Receivables
| 26.962 | 47.086 | 22.497 | 12.881 | 7.862 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 3.043 | 4.224 | 4.106 | 2.644 | 0.346 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 11.813 | 19.821 | 2.88 | 0.559 | 1.485 | 6.413 | 1.954 | 2.084 | 1.967 | 2.027 | 1.982 | 0.563 | 0.354 |
| Total Current Assets
| 233.921 | 326.75 | 258.098 | 289.539 | 273.665 | 334.612 | 148.423 | 131.636 | 177.6 | 207.751 | 157.956 | 0.954 | 6.866 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 4.882 | 7.377 | 1.642 | 2.219 | 3.046 | 3.863 | 2.185 | 2.836 | 3.483 | 2.754 | 0.24 | 0.327 | 0.328 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0.301 | 0.633 | 0.637 | 24.215 | 2.016 | 2.001 | 29.396 | 45.434 | 33.878 | 8.658 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.334 | 23.412 | 44.928 | -2.923 | 16.236 | 0.716 | 0.29 | 0.479 | 0.482 | 1.174 | 0.03 | 0.03 | 0.03 |
| Total Non-Current Assets
| 6.517 | 31.422 | 47.207 | 23.511 | 21.298 | 6.58 | 31.871 | 48.749 | 37.843 | 12.586 | 0.27 | 0.357 | 0.358 |
| Total Assets
| 240.438 | 358.172 | 305.305 | 313.05 | 294.963 | 341.192 | 180.294 | 180.385 | 215.443 | 220.337 | 158.226 | 1.311 | 7.224 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 3.123 | 2.773 | 1.603 | 4.45 | 0.985 | 4.332 | 5.665 | 4.751 | 3.808 | 6.288 | 1.74 | 1.076 | 1.142 |
| Short Term Debt
| 3.308 | 2.872 | 2.316 | 1.917 | 1.646 | 32.883 | 21.748 | -0.28 | -0.206 | 0 | 0.784 | 0.764 | 0.759 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 69.121 | 0.297 | 2.341 | 9.362 | 21.921 | 0.28 | 0.206 | 0 | 0.079 | 0.066 | 0.2 |
| Other Current Liabilities
| 63.048 | 60.263 | 0.678 | -6.367 | 41.378 | 0.327 | 0.133 | 11.725 | 11.324 | 6.013 | 0.305 | 0.024 | 0.016 |
| Total Current Liabilities
| 69.479 | 65.908 | 73.718 | 0.297 | 46.35 | 46.904 | 49.467 | 16.476 | 15.132 | 12.301 | 2.908 | 1.93 | 2.117 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 170.919 | 170.105 | 169.293 | 117.928 | 109.857 | 102.664 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 132.479 | 132.718 | 132.998 | 73.088 | 4.533 | 4.532 | 0 | 0 | 1.946 | 0 | 0.384 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 2.789 | -132.718 | -132.998 | -73.088 | 73.588 | -93.502 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.978 | 204.723 | 215.685 | 144.279 | 57.211 | 97.424 | 1.363 | 1.666 | 0 | 1.242 | 0 | 27.258 | 17.758 |
| Total Non-Current Liabilities
| 307.165 | 374.828 | 384.978 | 262.207 | 245.189 | 111.118 | 1.363 | 1.666 | 1.946 | 1.242 | 0.384 | 27.258 | 17.758 |
| Total Liabilities
| 376.644 | 374.828 | 384.978 | 262.504 | 245.189 | 158.022 | 50.83 | 18.142 | 17.078 | 13.543 | 3.292 | 29.188 | 19.875 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27.258 | 0 |
| Common Stock
| 0.012 | 0.012 | 0.008 | 0.007 | 0.007 | 0.006 | 0.005 | 0.004 | 0.004 | 0.003 | 0.003 | 0 | 0 |
| Retained Earnings
| -1,487.038 | -1,343.939 | -1,178.648 | -1,069.611 | -873.338 | -673.748 | -495.341 | -366.104 | -256.527 | -138.346 | -62.569 | -28.622 | -12.734 |
| Accumulated Other Comprehensive Income/Loss
| -0.161 | -0.638 | 0.191 | 0.518 | -0.037 | -0.244 | -0.217 | -0.274 | -0.282 | -0.029 | -0.35 | -0.206 | -0.084 |
| Other Total Stockholders Equity
| 1,350.981 | 1,327.909 | 1,098.776 | 1,119.632 | 923.142 | 857.156 | 625.017 | 528.617 | 455.17 | 345.166 | 217.85 | -26.307 | 0.167 |
| Total Shareholders Equity
| -136.206 | -16.656 | -79.673 | 50.546 | 49.774 | 183.17 | 129.464 | 162.243 | 198.365 | 206.794 | 154.934 | -27.877 | -12.651 |
| Total Equity
| -136.206 | -16.656 | -79.673 | 50.546 | 49.774 | 183.17 | 129.464 | 162.243 | 198.365 | 206.794 | 154.934 | -27.877 | -12.651 |
| Total Liabilities & Shareholders Equity
| 240.438 | 358.172 | 305.305 | 313.05 | 294.963 | 341.192 | 180.294 | 180.385 | 215.443 | 220.337 | 158.226 | 1.311 | 7.224 |